Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine premedication for attenuation of the intubation stress response
PACTR202402608586239Phase 4Recruiting
- Sponsor
- National Liver Institute
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine (3 arms), sponsored by National Liver Institute. Primary endpoint: Change in analgesia nociception index during laryngoscopy and intubation. Started Jan 2024; status: recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on PACTR202402608586239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202402608586239.